Editorial comment to real-world outcomes of pembrolizumab for platinum refractory advanced urothelial carcinoma: Efficacy, safety, and evidence for trial-unfit patients.
Yusuke GotoPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)